0(0%) Volume: 1,822,642 1:08AM EDT| Market Cap : 7.1 B | Enterprise Value : 10.6 B | P/E(TTM) : 1460.50 | P/B : 5.61 |
|---|
AXTA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AXTA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash-to-Debt | 0.13 |
AXTA's Cash-to-Debt is ranked lower than
85% of the 1115 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.76 vs. AXTA: 0.13 ) Ranked among companies with meaningful Cash-to-Debt only. |
AXTA'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06 Med: 0.13 Max: N/A Current: 0.13 |
| Equity-to-Asset | 0.19 |
AXTA's Equity-to-Asset is ranked lower than
93% of the 1071 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.56 vs. AXTA: 0.19 ) Ranked among companies with meaningful Equity-to-Asset only. |
AXTA'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.17 Med: 0.18 Max: 0.21 Current: 0.19 |
| Interest Coverage | 2.05 |
AXTA's Interest Coverage is ranked lower than
89% of the 1005 Companies in the Global Specialty Chemicals industry. ( Industry Median: 35.29 vs. AXTA: 2.05 ) Ranked among companies with meaningful Interest Coverage only. |
AXTA'
s Interest Coverage Range Over the Past 10 Years
Min: 0.12 Med: 2.34 Max: No Debt Current: 2.05 |
| Piotroski F-Score: 5 |
|
| Altman Z-Score: 1.71 |
|
| Beneish M-Score: -2.54 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating Margin % | 7.46 |
AXTA's Operating Margin % is ranked higher than
62% of the 1094 Companies in the Global Specialty Chemicals industry. ( Industry Median: 7.85 vs. AXTA: 7.46 ) Ranked among companies with meaningful Operating Margin % only. |
AXTA'
s Operating Margin % Range Over the Past 10 Years
Min: 0.62 Med: 9.02 Max: 11.4 Current: 7.46 |
| Net Margin % | 0.17 |
AXTA's Net Margin % is ranked lower than
76% of the 1094 Companies in the Global Specialty Chemicals industry. ( Industry Median: 5.68 vs. AXTA: 0.17 ) Ranked among companies with meaningful Net Margin % only. |
AXTA'
s Net Margin % Range Over the Past 10 Years
Min: -5.64 Med: 1.65 Max: 5.72 Current: 0.17 |
| ROE % | 0.57 |
AXTA's ROE % is ranked lower than
62% of the 1083 Companies in the Global Specialty Chemicals industry. ( Industry Median: 8.97 vs. AXTA: 0.57 ) Ranked among companies with meaningful ROE % only. |
AXTA'
s ROE % Range Over the Past 10 Years
Min: -15.75 Med: 3.78 Max: 29.25 Current: 0.57 |
| ROA % | 0.11 |
AXTA's ROA % is ranked lower than
75% of the 1122 Companies in the Global Specialty Chemicals industry. ( Industry Median: 4.71 vs. AXTA: 0.11 ) Ranked among companies with meaningful ROA % only. |
AXTA'
s ROA % Range Over the Past 10 Years
Min: -4.68 Med: 0.72 Max: 16.9 Current: 0.11 |
| ROC (Joel Greenblatt) % | 15.64 |
AXTA's ROC (Joel Greenblatt) % is ranked higher than
66% of the 1113 Companies in the Global Specialty Chemicals industry. ( Industry Median: 14.66 vs. AXTA: 15.64 ) Ranked among companies with meaningful ROC (Joel Greenblatt) % only. |
AXTA'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.44 Med: 21.9 Max: 63.68 Current: 15.64 |
| 3-Year Revenue Growth Rate | -1.40 |
AXTA's 3-Year Revenue Growth Rate is ranked lower than
58% of the 989 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.50 vs. AXTA: -1.40 ) Ranked among companies with meaningful 3-Year Revenue Growth Rate only. |
AXTA'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0 Med: 0 Max: -1.4 Current: -1.4 |
| 3-Year EBITDA Growth Rate | 28.00 |
AXTA's 3-Year EBITDA Growth Rate is ranked higher than
82% of the 889 Companies in the Global Specialty Chemicals industry. ( Industry Median: 8.60 vs. AXTA: 28.00 ) Ranked among companies with meaningful 3-Year EBITDA Growth Rate only. |
AXTA'
s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0 Med: 0 Max: 28 Current: 28 |
| Chris Davis 11,400 sh (New) Caxton Associates 150,000 sh (New) Lou Simpson 5,286,522 sh (New) Steven Cohen 320,300 sh (New) Diamond Hill Capital 7,630,184 sh (+154.24%) Barrow, Hanley, Mewhinney & Strauss 3,848,380 sh (+47.84%) | First Eagle Investment 3,718,020 sh (unchged) Warren Buffett 23,324,000 sh (unchged) Jerome Dodson 500,000 sh (unchged) | Glenn Greenberg 3,005,422 sh (-0.52%) Columbia Wanger 1,442,370 sh (-9.15%) Jim Simons 904,900 sh (-39.67%) Paul Tudor Jones 22,406 sh (-48.40%) |
| Chris Davis 3,903,956 sh (+34145.23%) Barrow, Hanley, Mewhinney & Strauss 5,898,523 sh (+53.27%) Glenn Greenberg 4,443,376 sh (+47.85%) Diamond Hill Capital 10,087,585 sh (+32.21%) Jerome Dodson 650,000 sh (+30.00%) Lou Simpson 5,451,489 sh (+3.12%) | Warren Buffett 23,324,000 sh (unchged) | Paul Tudor Jones Sold Out Caxton Associates Sold Out Steven Cohen Sold Out Jim Simons 843,800 sh (-6.75%) Columbia Wanger 1,293,494 sh (-10.32%) First Eagle Investment 2,253,397 sh (-39.39%) |
| First Pacific Advisors 64,300 sh (New) Joel Greenblatt 122,434 sh (New) Steven Cohen 626,100 sh (New) Paul Tudor Jones 109,498 sh (New) Robert Olstein 241,940 sh (New) Chris Davis 6,699,596 sh (+71.61%) Jerome Dodson 800,000 sh (+23.08%) Lou Simpson 6,110,726 sh (+12.09%) Jim Simons 927,500 sh (+9.92%) Diamond Hill Capital 10,089,171 sh (+0.02%) | Warren Buffett 23,324,000 sh (unchged) | Barrow, Hanley, Mewhinney & Strauss 5,864,140 sh (-0.58%) Glenn Greenberg 4,400,048 sh (-0.98%) First Eagle Investment 1,216,112 sh (-46.03%) Columbia Wanger 406,899 sh (-68.54%) |
| Lou Simpson 6,731,791 sh (+10.16%) Chris Davis 7,228,390 sh (+7.89%) Robert Olstein 247,959 sh (+2.49%) | Barrow, Hanley, Mewhinney & Strauss 5,864,140 sh (unchged) First Pacific Advisors 64,300 sh (unchged) Warren Buffett 23,324,000 sh (unchged) Jerome Dodson 800,000 sh (unchged) | Joel Greenblatt Sold Out Diamond Hill Capital 9,984,150 sh (-1.04%) Glenn Greenberg 3,859,691 sh (-12.28%) First Eagle Investment 1,009,457 sh (-16.99%) Jim Simons 637,800 sh (-31.23%) Steven Cohen 417,622 sh (-33.30%) Columbia Wanger 175,701 sh (-56.82%) Paul Tudor Jones 31,787 sh (-70.97%) |
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Chris Davis | 2017-06-30 | Add 7.89% | 0.07% | $30.92 - $33.76 | $ 29.21 | -9% | 7,228,390 |  |
| Lou Simpson | 2017-06-30 | Add 10.16% | 0.72% | $30.92 - $33.76 | $ 29.21 | -9% | 6,731,791 | |
| Glenn Greenberg | 2017-06-30 | Reduce -12.28% | 0.83% | $30.92 - $33.76 | $ 29.21 | -9% | 3,859,691 | |
| First Eagle Investment | 2017-06-30 | Reduce -16.99% | 0.02% | $30.92 - $33.76 | $ 29.21 | -9% | 1,009,457 | |
| Robert Olstein | 2017-06-30 | Add 2.49% | 0.02% | $30.92 - $33.76 | $ 29.21 | -9% | 247,959 | |
| Joel Greenblatt | 2017-06-30 | Sold Out | 0.05% | $30.92 - $33.76 | $ 29.21 | -9% | 0 | |
| Chris Davis | 2017-03-31 | Add 71.61% | 0.39% | $27.28 - $32.61 | $ 29.21 | -2% | 6,699,596 | |
| Lou Simpson | 2017-03-31 | Add 12.09% | 0.81% | $27.28 - $32.61 | $ 29.21 | -2% | 6,110,726 | |
| Barrow, Hanley, Mewhinney & Strauss | 2017-03-31 | Reduce -0.58% | $27.28 - $32.61 | $ 29.21 | -2% | 5,864,140 | | |
| Glenn Greenberg | 2017-03-31 | Reduce -0.98% | 0.06% | $27.28 - $32.61 | $ 29.21 | -2% | 4,400,048 | |
| First Eagle Investment | 2017-03-31 | Reduce -46.03% | 0.07% | $27.28 - $32.61 | $ 29.21 | -2% | 1,216,112 | |
| Robert Olstein | 2017-03-31 | New Buy | 1% | $27.28 - $32.61 | $ 29.21 | -2% | 241,940 | |
| Joel Greenblatt | 2017-03-31 | New Buy | 0.05% | $27.28 - $32.61 | $ 29.21 | -2% | 122,434 | |
| Barrow, Hanley, Mewhinney & Strauss | 2016-12-31 | Add 53.27% | 0.08% | $24.53 - $28.11 | $ 29.21 | 11% | 5,898,523 | |
| Lou Simpson | 2016-12-31 | Add 3.12% | 0.19% | $24.53 - $28.11 | $ 29.21 | 11% | 5,451,489 | |
| Glenn Greenberg | 2016-12-31 | Add 47.85% | 1.86% | $24.53 - $28.11 | $ 29.21 | 11% | 4,443,376 | |
| Chris Davis | 2016-12-31 | Add 34145.23% | 0.46% | $24.53 - $28.11 | $ 29.21 | 11% | 3,903,956 | |
| First Eagle Investment | 2016-12-31 | Reduce -39.39% | 0.11% | $24.53 - $28.11 | $ 29.21 | 11% | 2,253,397 | |
| Lou Simpson | 2016-09-30 | New Buy | 5.95% | $26.05 - $28.97 | $ 29.21 | 4% | 5,286,522 | |
| Barrow, Hanley, Mewhinney & Strauss | 2016-09-30 | Add 47.84% | 0.06% | $26.05 - $28.97 | $ 29.21 | 4% | 3,848,380 | |
| Glenn Greenberg | 2016-09-30 | Reduce -0.52% | 0.02% | $26.05 - $28.97 | $ 29.21 | 4% | 3,005,422 | |
| Chris Davis | 2016-09-30 | New Buy | $26.05 - $28.97 | $ 29.21 | 4% | 11,400 | |
More recent guru trades are included for Premium Members only!! More recent guru trades are included for USA Subscribe Members only!!
What is Peter Lynch Charts )| Industry: | Chemicals » Specialty Chemicals NAICS: 325510 | |
|---|---|---|
| Compare: | NYSE:RPM, NYSE:CC, NYSE:VAL, NYSE:WLK, NYSE:OLN, NYSE:NEU, NYSE:GRA, NYSE:IFF, NYSE:PAH, NYSE:CBT, NYSE:SXT, NYSE:POL, NYSE:FUL, NYSE:NGVT, NYSE:KRO, NYSE:CHMT, NYSE:GCP, NYSE:KWR, NYSE:ALB, NYSE:SCL » details | |
| Traded in other countries: | 9AX.Germany, | |
| Headquarter Location: | USA |
| vs
industry |
vs
history |
||
|---|---|---|---|
| PE Ratio | 1460.50 |
AXTA's PE Ratio is ranked lower than
93% of the 920 Companies in the Global Specialty Chemicals industry. ( Industry Median: 19.63 vs. AXTA: 1460.50 ) Ranked among companies with meaningful PE Ratio only. |
AXTA'
s PE Ratio Range Over the Past 10 Years
Min: 40.14 Med: 101.91 Max: 1688 Current: 1460.5 |
| Forward PE Ratio | 21.28 |
AXTA's Forward PE Ratio is ranked lower than
69% of the 91 Companies in the Global Specialty Chemicals industry. ( Industry Median: 18.18 vs. AXTA: 21.28 ) Ranked among companies with meaningful Forward PE Ratio only. |
N/A |
| PE Ratio without NRI | 1460.50 |
AXTA's PE Ratio without NRI is ranked lower than
93% of the 919 Companies in the Global Specialty Chemicals industry. ( Industry Median: 19.93 vs. AXTA: 1460.50 ) Ranked among companies with meaningful PE Ratio without NRI only. |
AXTA'
s PE Ratio without NRI Range Over the Past 10 Years
Min: 40.14 Med: 101.91 Max: 1688 Current: 1460.5 |
| PB Ratio | 5.61 |
AXTA's PB Ratio is ranked lower than
89% of the 1065 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.98 vs. AXTA: 5.61 ) Ranked among companies with meaningful PB Ratio only. |
AXTA'
s PB Ratio Range Over the Past 10 Years
Min: 4.87 Med: 5.98 Max: 8.19 Current: 5.61 |
| PS Ratio | 1.70 |
AXTA's PS Ratio is ranked lower than
61% of the 1072 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.37 vs. AXTA: 1.70 ) Ranked among companies with meaningful PS Ratio only. |
AXTA'
s PS Ratio Range Over the Past 10 Years
Min: 1.3 Med: 1.66 Max: 1.97 Current: 1.7 |
| Price-to-Free-Cash-Flow | 20.68 |
AXTA's Price-to-Free-Cash-Flow is ranked higher than
54% of the 345 Companies in the Global Specialty Chemicals industry. ( Industry Median: 19.42 vs. AXTA: 20.68 ) Ranked among companies with meaningful Price-to-Free-Cash-Flow only. |
AXTA'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.9 Med: 20.96 Max: 144.5 Current: 20.68 |
| Price-to-Operating-Cash-Flow | 15.07 |
AXTA's Price-to-Operating-Cash-Flow is ranked lower than
60% of the 442 Companies in the Global Specialty Chemicals industry. ( Industry Median: 10.94 vs. AXTA: 15.07 ) Ranked among companies with meaningful Price-to-Operating-Cash-Flow only. |
AXTA'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.4 Med: 14.57 Max: 35.31 Current: 15.07 |
| EV-to-EBIT | 34.06 |
AXTA's EV-to-EBIT is ranked lower than
71% of the 954 Companies in the Global Specialty Chemicals industry. ( Industry Median: 15.68 vs. AXTA: 34.06 ) Ranked among companies with meaningful EV-to-EBIT only. |
AXTA'
s EV-to-EBIT Range Over the Past 10 Years
Min: 18.3 Med: 23.65 Max: 37.4 Current: 34.06 |
| EV-to-EBITDA | 16.42 |
AXTA's EV-to-EBITDA is ranked lower than
59% of the 975 Companies in the Global Specialty Chemicals industry. ( Industry Median: 12.03 vs. AXTA: 16.42 ) Ranked among companies with meaningful EV-to-EBITDA only. |
AXTA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11 Med: 13.4 Max: 18 Current: 16.42 |
| Current Ratio | 2.13 |
AXTA's Current Ratio is ranked higher than
62% of the 1091 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.85 vs. AXTA: 2.13 ) Ranked among companies with meaningful Current Ratio only. |
AXTA'
s Current Ratio Range Over the Past 10 Years
Min: 1.95 Med: 2.16 Max: 2.4 Current: 2.13 |
| Quick Ratio | 1.54 |
AXTA's Quick Ratio is ranked higher than
61% of the 1091 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.33 vs. AXTA: 1.54 ) Ranked among companies with meaningful Quick Ratio only. |
AXTA'
s Quick Ratio Range Over the Past 10 Years
Min: 1.37 Med: 1.53 Max: 1.71 Current: 1.54 |
| Days Inventory | 76.67 |
AXTA's Days Inventory is ranked lower than
61% of the 1052 Companies in the Global Specialty Chemicals industry. ( Industry Median: 63.90 vs. AXTA: 76.67 ) Ranked among companies with meaningful Days Inventory only. |
AXTA'
s Days Inventory Range Over the Past 10 Years
Min: 29.31 Med: 68.57 Max: 76.67 Current: 76.67 |
| Days Sales Outstanding | 73.54 |
AXTA's Days Sales Outstanding is ranked lower than
53% of the 887 Companies in the Global Specialty Chemicals industry. ( Industry Median: 62.15 vs. AXTA: 73.54 ) Ranked among companies with meaningful Days Sales Outstanding only. |
AXTA'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.05 Med: 57.43 Max: 73.54 Current: 73.54 |
| Days Payable | 68.69 |
AXTA's Days Payable is ranked higher than
64% of the 845 Companies in the Global Specialty Chemicals industry. ( Industry Median: 49.97 vs. AXTA: 68.69 ) Ranked among companies with meaningful Days Payable only. |
AXTA'
s Days Payable Range Over the Past 10 Years
Min: 48.53 Med: 58.41 Max: 68.69 Current: 68.69 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.70 |
AXTA's 3-Year Average Share Buyback Ratio is ranked higher than
51% of the 570 Companies in the Global Specialty Chemicals industry. ( Industry Median: -2.10 vs. AXTA: -1.70 ) Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only. |
AXTA'
s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.7 Med: 0 Max: 0 Current: -1.7 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price-to-Median-PS-Value | 1.03 |
AXTA's Price-to-Median-PS-Value is ranked higher than
58% of the 1046 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.28 vs. AXTA: 1.03 ) Ranked among companies with meaningful Price-to-Median-PS-Value only. |
AXTA'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.82 Med: 0.98 Max: 1.15 Current: 1.03 |
| Earnings Yield (Greenblatt) % | 2.95 |
AXTA's Earnings Yield (Greenblatt) % is ranked lower than
61% of the 1118 Companies in the Global Specialty Chemicals industry. ( Industry Median: 5.33 vs. AXTA: 2.95 ) Ranked among companies with meaningful Earnings Yield (Greenblatt) % only. |
AXTA'
s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.7 Med: 4.2 Max: 5.5 Current: 2.95 |
| Revenue (TTM) (Mil) $ | 4,172.00 |
|---|---|
| EPS (TTM) $ | 0.02 |
| Short Percentage of Float | 1.76% |
| 52-Week Range $ | 24.27 - 34.10 |
| Shares Outstanding (Mil) | 243.16 |
| Dec17 | Dec18 | Dec19 | |
|---|---|---|---|
| Revenue (Mil $) | 4,347 | 4,601 | 4,905 |
| EPS ($) | 1.30 | 1.67 | 1.83 |
| EPS without NRI ($) | 1.30 | 1.67 | 1.83 |
| EPS Growth Rate (Future 3Y To 5Y Estimate) | 21.45% | ||
| Dividends per Share ($) | |||
GF Chat
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP